These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9050088)

  • 1. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. II. The elevated plus-maze.
    Rodgers RJ; Cutler MG; Jackson JE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):295-303. PubMed ID: 9050088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. I. Social interactions.
    Cutler MG; Rodgers RJ; Jackson JE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):287-93. PubMed ID: 9050087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze.
    Rodgers RJ; Cutler MG; Jackson JE
    Pharmacol Biochem Behav; 1997; 57(1-2):127-36. PubMed ID: 9164563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
    Cao BJ; Rodgers RJ
    Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
    Rodgers RJ; Cole JC; Tredwell JM
    Psychopharmacology (Berl); 1995 Feb; 117(3):306-12. PubMed ID: 7770606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice.
    Cao BJ; Rodgers RJ
    Psychopharmacology (Berl); 1998 Oct; 139(3):185-94. PubMed ID: 9784072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of buspirone complex with glycyrrhizic acid on behavior of mice with anxious-depressive state].
    Fomina MK; Avgustinovich DF; Tolstikova TG
    Ross Fiziol Zh Im I M Sechenova; 2014 Jul; 100(7):808-19. PubMed ID: 25669106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
    Ramamoorthy R; Radhakrishnan M; Borah M
    Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose dependent effects of serotonergic agents on anxiety.
    Kolcsar M; Gáll Z; Dogaru MT
    Acta Physiol Hung; 2014 Dec; 101(4):479-87. PubMed ID: 25532957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats.
    Nowakowska E; Kus K; Chodera A; Rybakowski J
    Arzneimittelforschung; 2000 Jan; 50(1):5-10. PubMed ID: 10683709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant activity of the antidepressant drug, tianeptine, against pentylenetetrazole-induced seizures mitigates cognitive impairment in rats.
    Reeta Kh; Prabhakar P; Gupta YK
    Behav Pharmacol; 2016 Oct; 27(7):623-32. PubMed ID: 27561095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the serotonin agonists 8-OH-DPAT, buspirone, and DOI on water maze performance.
    Kant GJ; Wylie RM; Chu K; Ghosh S
    Pharmacol Biochem Behav; 1998 Mar; 59(3):729-35. PubMed ID: 9512079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.
    Cole JC; Rodgers RJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):288-96. PubMed ID: 7838922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
    Moser PC
    Psychopharmacology (Berl); 1989; 99(1):48-53. PubMed ID: 2528779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors.
    Kumar JR; Rajkumar R; Lee LC; Dawe GS
    Neuropharmacology; 2016 Nov; 110(Pt A):1-14. PubMed ID: 27436722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Serotonin 5-HT
    Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
    ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies on the enhancement of serotonin reuptake by tianeptine.
    De Simoni MG; De Luigi A; Clavenna A; Manfridi A
    Brain Res; 1992 Mar; 574(1-2):93-7. PubMed ID: 1379111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
    de Oliveira Citó Mdo C; da Silva FC; Silva MI; Moura BA; Macêdo DS; Woods DJ; Fonteles MM; de Vasconcelos SM; de Sousa FC
    Behav Brain Res; 2012 May; 231(1):116-23. PubMed ID: 22374255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.